Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 3:25 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1417–1440 of 8,691 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Cognitive Impairment
Interventions: metaxalone m640 mg, tizanidine 8mg; Drug
Lead sponsor: Primus Pharmaceuticals; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Peoria, Arizona

Conditions: Adolescent Idiopathic Scoliosis (AIS), Neuromuscular Scoliosis
Interventions: Not listed
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 10 Years to 17 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2031
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Hypertensive Disorder of Pregnancy, Pulmonary Arterial Hypertension, Intrauterine Growth Restriction
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Open Angle Glaucoma
Interventions: Suprachoroidal Dissection Instrument (SDI); Device
Lead sponsor: iScience Interventional Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Hyperpigmentation, Post-inflammatory Hyperpigmentation, Acne
Interventions: Topical Cetyl Tranexamate Mesylate; Other
Lead sponsor: Integrative Skin Science and Research; Industry
Eligibility: 14 Years to 45 Years
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Vaginal Atrophy, Genitourinary System; Disorder, Female, Vaginal Abnormality, Sexual Dysfunction, Sexual Problem
Interventions: Viveve®; Device
Lead sponsor: W. Grant Stevens, MD; Other
Eligibility: 18 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Marina del Rey, California

Conditions: Subjects Requesting and Requiring an Open Rhinoplasty
Interventions: ARTISS human fibrin sealant; Biological
Lead sponsor: DeNova Research; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Knee Arthroplasty
Interventions: Aquamantys Device, Standard of care treatment for hemostasis during a total knee arthroplasty.; Device · Other
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 111 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: The Bronx, New York

Conditions: Labor Pain, Early Labor
Interventions: Morphine Sulfate and Promethazine; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Highly-sensitized Kidney Transplant Recipients
Interventions: everolimus + low-dose tacrolimus; Drug
Lead sponsor: Joseph Kahwaji, MD, MPH; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Vascular Injury
Interventions: Vascular Injury; Procedure
Lead sponsor: Methodist Health System; Other
Eligibility: 16 Years and older
Enrollment: 5,718 participants
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Surgical Wound
Interventions: Synthetic Electrospun Fiber Matrix; Device
Lead sponsor: Acera Surgical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Degenerative Lumbar Spinal Stenosis
Interventions: Single-Level Posterior Decompression, DIAM Spinal Stabilization, Fusion; Procedure · Device
Lead sponsor: Medtronic Spinal and Biologics; Industry
Eligibility: 35 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 9
States / cities: Fremont, California • Jacksonville, Florida • Melbourne, Florida + 6 more

Conditions: Cystic Fibrosis
Interventions: Not listed
Lead sponsor: Foundation for the National Institutes of Health; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 3
States / cities: Los Angeles, California • Minneapolis, Minnesota • Salt Lake City, Utah

Conditions: Bone Fracture, Opioid Use, Opioid Dependence
Interventions: SOC Pain Management, Early US Guided Nerve Block Administration; Other · Procedure
Lead sponsor: Wayne State University; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 2
States / cities: Detroit, Michigan

Conditions: Otitis Media
Interventions: OTO-201 (ciprofloxacin); Drug
Lead sponsor: Otonomy, Inc.; Industry
Eligibility: 6 Months to 17 Years
Enrollment: 501 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: San Diego, California

Conditions: Type 2 Diabetes Mellitus
Interventions: LY900014, Insulin Lispro, Insulin Glargine, Insulin Degludec, Metformin, SGLT2 inhibitor; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 933 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 32
States / cities: Fresno, California • La Mesa, California • Lancaster, California + 26 more

Conditions: Heart Failure, Multiple Myeloma
Interventions: Not listed
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania • Nashville, Tennessee

Conditions: Methylmalonic Acidemia (MMA)
Interventions: Not listed
Lead sponsor: Genespire Srl; Industry
Eligibility: Up to 16 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania • Pittsburgh, Pennsylvania

Conditions: Radiation Therapy Complication, Chemotherapeutic Toxicity
Interventions: Machine learning algorithm; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 311 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Lung Transplant
Interventions: Procedure; Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 3
States / cities: Baltimore, Maryland • Durham, North Carolina • Cleveland, Ohio

Conditions: Prostate Cancer
Interventions: NanoTherm Ablation; Device
Lead sponsor: MagForce USA; Industry
Eligibility: 40 Years to 85 Years · Male only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 4
States / cities: Tampa, Florida • Austin, Texas • San Antonio, Texas + 1 more

Conditions: Alzheimer s Disease, Mild Cognitive Impairment (MCI)
Interventions: Not listed
Lead sponsor: Crownlands; Industry
Eligibility: 55 Years and older
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Germantown, Maryland

Conditions: Oncology, DIPG, DMG
Interventions: Not listed
Lead sponsor: xCures; Industry
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Los Altos, California

Search by objective public record fields.

Assess the Effect of Metaxalone 640 mg (M640) Compared to Tizanidine 8 mg on Truck Driving Ability and Cognition

UNderstanding the Causes Of Idiopathic Scoliosis Through the Longitudinal Analysis of Proteomic Markers: the UNCOIL Study

A Prospective Longitudinal Observational Cohort Study of Pregnant Women Residing at High Altitude in Bolivia

Surgical Treatment of Refractory Open Angle Glaucoma

The Effects of Cetyl Tranexamate Mesylate on the Appearance of Acne-Related Hyperpigmentation

A Prospective Trial to Assess Breast Cancer Survivors and Vaginal Atrophy Treatment Outcomes

A Study Evaluating the Efficacy and Safety of ARTISS Human Fibrin Sealant as Used in External Rhinoplasty

Unipolar vs. Bipolar Hemostasis in Total Knee Arthroplasty: A Prospective Randomized Trial

Therapeutic Rest to Delay Admission in Early Labor: A Prospective Study on Morphine Sleep

Role of Everolimus in Highly Sensitized Patients

The PROspective Observational Vascular Injury Trial (PROOVIT)

A Prospective, Single-arm, Clinical Trial of Electrospun Fiber Matrix (Restrata) in the Treatment of Surgical Defects Secondary to Resection of Malignant Cutaneous Neoplasms

DIAM™ Spinal Stabilization System vs. Decompression, Formerly vs. Posterolateral Fusion

Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis

Does Early Administration of Ultrasound Guided Regional Anesthesia for Long Bone Fractures Effect Long Term Patient Opioid Usage

Open-Label Study of OTO-201 in Pediatric Subjects With a History of Otitis Media Requiring Tympanostomy Tubes

A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes

Prospective Observation of Cardiac Safety With Proteasome Inhibition

A Prospective Study of Pediatric Participants up to 16 Years of Age With Methylmalonic Acidemia (MMA) Due to Mutations in the MMUT Gene

System for High-Intensity Evaluation During Radiotherapy

PREDICT Cytomegalovirus (CMV)

Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer

Crownlands Observing Progression With Neurons Study

xPedite: A Study to Expedite DIPG and DMG Research